6/13
08:47 am
gern
Geron Corporation's (NASDAQ:GERN) large institutional owners must be happy as stock continues to impress, up 27% over the past week [Yahoo! Finance]
Medium
Report
Geron Corporation's (NASDAQ:GERN) large institutional owners must be happy as stock continues to impress, up 27% over the past week [Yahoo! Finance]
6/10
01:05 pm
gern
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up [Yahoo! Finance]
Low
Report
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up [Yahoo! Finance]
6/10
11:06 am
gern
Geron Co. (NASDAQ: GERN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $9.00 price target on the stock.
Low
Report
Geron Co. (NASDAQ: GERN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $9.00 price target on the stock.
6/10
09:03 am
gern
Geron Co. (NASDAQ: GERN) had its price target raised by analysts at Stifel Nicolaus from $6.00 to $7.00. They now have a "buy" rating on the stock.
Medium
Report
Geron Co. (NASDAQ: GERN) had its price target raised by analysts at Stifel Nicolaus from $6.00 to $7.00. They now have a "buy" rating on the stock.
6/8
06:45 am
gern
Is Geron Stock a Buy Following Its First New Drug Approval? [Yahoo! Finance]
Medium
Report
Is Geron Stock a Buy Following Its First New Drug Approval? [Yahoo! Finance]
6/7
04:44 pm
gern
FDA Roundup: June 7, 2024 [Yahoo! Finance]
High
Report
FDA Roundup: June 7, 2024 [Yahoo! Finance]
6/7
12:41 pm
gern
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA's Approval of a Telomerase Inhibitor Agent Therapy [Yahoo! Finance]
Low
Report
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA's Approval of a Telomerase Inhibitor Agent Therapy [Yahoo! Finance]
6/7
10:05 am
gern
Geron Co. (NASDAQ: GERN) had its price target raised by analysts at Needham & Company LLC from $5.00 to $6.00. They now have a "buy" rating on the stock.
Medium
Report
Geron Co. (NASDAQ: GERN) had its price target raised by analysts at Needham & Company LLC from $5.00 to $6.00. They now have a "buy" rating on the stock.
6/7
09:04 am
gern
Geron Co. (NASDAQ: GERN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $7.00 price target on the stock.
Low
Report
Geron Co. (NASDAQ: GERN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $7.00 price target on the stock.
6/7
04:35 am
gern
FDA approves Geron's RYTELO for MDS associated anaemia [Yahoo! Finance]
Medium
Report
FDA approves Geron's RYTELO for MDS associated anaemia [Yahoo! Finance]
6/6
10:06 pm
gern
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia [Yahoo! Finance]
High
Report
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia [Yahoo! Finance]
6/6
09:58 pm
gern
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
High
Report
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
5/16
04:30 pm
gern
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/15
04:09 pm
gern
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors [Yahoo! Finance]
Low
Report
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors [Yahoo! Finance]
5/3
10:40 am
gern
Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/3
07:00 am
gern
This Is Why Geron Corporation's (NASDAQ:GERN) CEO Compensation Looks Appropriate [Yahoo! Finance]
Low
Report
This Is Why Geron Corporation's (NASDAQ:GERN) CEO Compensation Looks Appropriate [Yahoo! Finance]
5/3
12:39 am
gern
Geron (GERN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Geron (GERN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/2
03:02 pm
gern
Geron Co. (NASDAQ: GERN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
Neutral
Report
Geron Co. (NASDAQ: GERN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $5.00 price target on the stock.
5/2
09:39 am
gern
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
5/2
07:13 am
gern
Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
Medium
Report
Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
5/2
07:00 am
gern
Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
Medium
Report
Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
4/30
01:53 pm
gern
Baird downgrades Geron to neutral, cites valuation concerns [Seeking Alpha]
Low
Report
Baird downgrades Geron to neutral, cites valuation concerns [Seeking Alpha]
4/30
07:15 am
gern
Geron Co. (NASDAQ: GERN) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $4.50 price target on the stock.
Medium
Report
Geron Co. (NASDAQ: GERN) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $4.50 price target on the stock.
4/29
07:25 am
gern
Geron Co. (NASDAQ: GERN) is now covered by analysts at TD Cowen. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Geron Co. (NASDAQ: GERN) is now covered by analysts at TD Cowen. They set a "buy" rating and a $10.00 price target on the stock.
4/25
04:30 pm
gern
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
Medium
Report
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024